James Synge
Partner @ Carthona Capital
Sydney, Australia
James Synge is a seed investor at Carthona Capital in Sydney focused on Health Care and Financial Services. James Synge is the Partner of Carthona Capital.
- Total investments:
- 12
- Last investment:
- Lead investor:
- 33%
Last updated:
For AI agents: llms.txt
Industries James Synge invests in
Stages James Synge invests in
Countries James Synge invests in
Contacts
| Type | Contact | Validation |
|---|---|---|
| Work email | ||
| Personal email | ||
| Work phone | ||
| Personal phone | ||
| Socials |
Investment Focus
Industry
- Health Care 3 (25%)
- Financial Services 3 (25%)
- FinTech 2 (17%)
- Medical 2 (17%)
- Marketplace 2 (17%)
Stage
- Seed 4 (33%)
- Venture - Series Unknown 2 (17%)
- Angel 1 (8%)
- Pre-Seed 1 (8%)
- Series A 1 (8%)
Country
- Australia 5 (42%)
- United States 3 (25%)
- United Kingdom 1 (8%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
| CoverRight operates at the intersection of digital health and finance. The company provides a digital-first Medicare navigation experience where consumers can receive customized Medicare plan suggestions. CoverRight collaborates with experienced Insurance, Banking, Pharmacy and Healthcare Provider partners nationwide to create a digitally-drivenand personalized Medicare enrollment and health navigation experience. | $1M / Venture - Series Unknown / Jul 01, 2024 | ||
| NayaOne is a fintech platform developer focused on delivering financial goods and services through collaborative efforts. The company's software enables financial institutions to quickly design and securely analyze new proposals before scaling them to production, giving businesses the freedom to respond and adapt to changing financial markets. | $4.7M / Series A / Feb 28, 2024 | ||
| Driva helps customers fight back against the car financing process - providing options and transparency to empower customer choice. | $4.5M / Seed / Mar 22, 2022 | ||
| Paratus Clinical Pty Ltd has been established to meet an increasing need for local service provision in Australia and New Zealand particularly for early Phase and late Phase (in Primary care) Clinical Research. Paratus Clinical provides clinical trial related services to pharmaceutical companies, contract research organizations (CROs),biotechnology companies, medical device companies and clinical sites. The site may be a single practice, network of practices, hospital based practice or a similar health care institution that has the infrastructure and staff to meet the requirements of the clinical trial protocol.Paratus Clinical has a qualified and experienced team of clinical research professionals who understand the intricacies of conducting clinical trials. Our experience with the entire process, from feasibility to site closeout, enables us to ensure timely and effective delivery at every stage of a trial. Our dedicated research team is comprised of highly skilled research professionals with many years of experience in all phases of trials and in a myriad of clinical indications. | $1.1M / Venture - Series Unknown / Oct 25, 2017 | ||
| Affiniti creates sophisticated digital marketing campaigns to help leading brands advertise to markets and channels that are otherwise difficult to access. | $505K / Jul 02, 2015 | ||
| There are exciting new advances in medical science and treatments all the time. However before any new treatment can improve the quality of life – or even save lives it must undergo a clinical trial.That’s where Neoclinical is helping. We want these advances made available to the public as soon as possible.To do that we match clinicaltrials with suitable patients – and suitable patients with clinical trials. Right now there are tens of thousands of clinical trials for new treatments. No matter who you are there’s probably one for you or someone you know. | $468.9K / Seed / Mar 03, 2015 | ||
| There are exciting new advances in medical science and treatments all the time. However before any new treatment can improve the quality of life – or even save lives it must undergo a clinical trial.That’s where Neoclinical is helping. We want these advances made available to the public as soon as possible.To do that we match clinicaltrials with suitable patients – and suitable patients with clinical trials. Right now there are tens of thousands of clinical trials for new treatments. No matter who you are there’s probably one for you or someone you know. | $337K / Seed / Aug 05, 2014 | ||
| As a multi-lender marketplace that allows borrowers to receive competitive loan offers from its vetted lenders, Credible empowers consumers to take control of their finances. After answering a few questions about themselves, consumers can receive rates without affecting their credit score or sharing their personal information with lenders untilthey're ready to proceed with an offer.Credible is fiercely independent and committed to delivering fair and unbiased financial solutions for millennials. | $700K / Seed / Jun 17, 2014 | ||
| The Search Party is an online recruitment marketplace that helps businesses find talent faster, easier, and at a lower cost. With an online pool of over 15 million agency-represented and validated candidate profiles, The Search Party has reduced the time to hire from an average of 60 days to 10 days. thesearchparty.comIn July 2015, The SearchParty acquired Job Advisor, a service that helps people discover employers to see if they're be the right cultural fit for the user. With over 15,000 employer profiles and reviews from current and past employees, Job Advisor is the perfect compliment to Search Party's hiring marketplace. jobadvisor.com.au | $572K / Angel / Jul 10, 2012 | ||
| The Search Party is an online recruitment marketplace that helps businesses find talent faster, easier, and at a lower cost. With an online pool of over 15 million agency-represented and validated candidate profiles, The Search Party has reduced the time to hire from an average of 60 days to 10 days. thesearchparty.comIn July 2015, The SearchParty acquired Job Advisor, a service that helps people discover employers to see if they're be the right cultural fit for the user. With over 15,000 employer profiles and reviews from current and past employees, Job Advisor is the perfect compliment to Search Party's hiring marketplace. jobadvisor.com.au | $146K / Angel / Mar 14, 2012 | ||
| See all 12 investments → | |||
Co-Investors
About Carthona Capital
Carthona Capital is a hands-on, proactive, and thematic venture capital investor based in Sydney, Australia that invests globally.Carthona Capital was founded in 2014 when a group of like-minded venture investors came together to invest on a deal-by-deal basis. Since then, Carthona Capital has shifted to a more traditional venture capital fundstructure, and is now deploying its third fund with approximately $400m in funds under management from a mix of Institutional (Superannuation), Family Office and High Net-worth investors.Carthona Capital likes to invest very early - their initial investment into a business is usually at the Pre-Seed, Seed, or Series A stages. Carthona then likes to follow-on strongly and continue to deploy larger amounts of capital as a business matures.
Carthona Capital Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Dean Dorrell
Partner
|
|||
Brad Shofer
Venture Partner
|
|||
Dave Gardiner
Co-Founder
|
|||
|
James Synge
Partner
|
|||
Jonathan Chow
Principal
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Recommended lists
FAQ
What does James Synge invest in?
James Synge invests primarily in Health Care, Financial Services and FinTech startups, most often at Seed and Venture - Series Unknown stage. Most of the 12 investments tracked by Shizune back companies in Australia. The Investment Focus section breaks down every industry, stage and country in the portfolio.
How do I contact James Synge?
Public channels for James Synge include LinkedIn. For a verified work email and phone number, create a free Shizune account — contact data is searched across 20+ sources and validated before delivery, so your outreach lands in the right inbox.
When did James Synge last invest?
The most recent investment recorded for James Synge closed in Jul 2024. Shizune tracks 12 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Sep 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
